Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
F
Fan, Yong
Allegheny Health Network
(
T0930-01-04
)
Zinc-Associated Peptide Coacervates for Recombinant Protein Capture and Release
Yong Fan
Favorite
Farnsworth, Nikki L
Colorado School of Mines
(
T0930-02-09
)
Polyplex Particle Size Alters Transgene Expression and Cell Viability in a Cell Type-Dependent Manner
Nikki L Farnsworth
Favorite
Farrell, Christopher
Merck & Co., Inc.
(
M1330-01-01
)
Utility of Small Angle X-Ray Scattering (SAXS) in Process Development, Characterization and Comparability of Lipid Nanoparticles, Liposomes and Fusion Proteins
Christopher Farrell
Favorite
Fasiku, Victoria
University of the Free State
(
M1430-01-01
)
Nanocapsules for Combined Delivery of Docetaxel and
Laguncularia Racemosa
Extract Against Oral Cancer Cells In Vitro
Victoria Fasiku
Favorite
Faya, Mbuso
University of KwaZulu-Natal
(
M1430-01-01
)
Nanocapsules for Combined Delivery of Docetaxel and
Laguncularia Racemosa
Extract Against Oral Cancer Cells In Vitro
Mbuso Faya
Favorite
Feng, Wen
Merck & Co., Inc.
(
T1130-02-06
)
Using Tasso-M20 Microsampling Device to Support a Clinical PK Study
Wen Feng
Favorite
Ferguson, Alex
Novartis
(
T1230-02-08
)
Reverse Translational Modeling for Early Benchmarking of Clinically Active Doses from In Vitro Cell Killing and T-Cell Activation Data for BCMAxCD3 T-Cell Engagers
Alex Ferguson
Favorite
Ferguson, Amarae
Mercer University
(
T1430-01-01
)
3-D Printed Rapidly Disintegrating Oral Films for Targeted Delivery of Aspirin in the Brain for Ischemic Stroke
Amarae Ferguson
Favorite
Ferris, Smantha
Waters Corporation
(
T1330-02-07
)
Quantitative Bioanalysis of Large Peptides and Proteins: Case Study of GLP-1 Receptor Agonist Semaglutide in Plasma
Smantha Ferris
Favorite
Finn, M.G.
Georgia Institute of Technology
(
T1330-01-02
)
Optimizing Gel Network Architecture for Oxanorbornadiene-Based Degradable Hydrogels
M.G. Finn
Favorite
Fischer, James
Pfizer Inc.
(
M1130-02-07
)
Embracing Singlicate Ligand Binding Biomarker Assays: A Case Study Comparing Duplicate vs Singlicate Analysis for the Determination of IL-6, IFN-gamma, and TNF-alpha in Human Sodium Heparin Plasma
James Fischer
Favorite
Fisher, Richard
Orion Therapeutics, Inc.
(
T1430-01-04
)
Long-Term Storage of Targeted Lipid Nanoparticles for Vascular Gene Therapies
Richard Fisher
Favorite
Forsström, Daniel
Gyros Protein Technologies
(
T1430-02-06
)
Immunogenicity Assessment of Both Anti-Drug Antibodies in Experimental Animals: Complexed with Drug or in Free Form Using an Automated Workflow
Daniel Forsström
Favorite
Forster, Seth
Merck & Co., Inc.
(
M1330-01-03
)
Engineering Extended-Release Profiles for Biologic Drugs via Chemical Crosslinking of Poloxamer 407 Hydrogels
Seth Forster
Favorite
Forte, Andre
Cerba Research
(
T1130-02-07
)
Mitigation of the Presence of Crosstalk in an ADA Bridging Assay Using the MSD Platform for the Detection of Antibodies against an Antibody-Drug Conjugate
Andre Forte
Favorite
Fox, Chris
Gyros Protein Technologies
(
M1330-02-08
)
Analysis of Pre-existing Anti-AAV Antibodies Using a Novel Nanoliter Total Antibody Assay: A Serotype-Independent Approach
Chris Fox
Favorite
(
T1430-02-06
)
Immunogenicity Assessment of Both Anti-Drug Antibodies in Experimental Animals: Complexed with Drug or in Free Form Using an Automated Workflow
Chris Fox
Favorite
Freeman, Michael
University of Tennessee
(
M1430-01-03
)
Enhanced Membrane Composition for Lipid Nanoparticle Vascular Drug Delivery
Michael Freeman
Favorite
(
T1430-01-04
)
Long-Term Storage of Targeted Lipid Nanoparticles for Vascular Gene Therapies
Michael Freeman
Favorite
French, Daniel
Qatch Technologies
(
M1030-01-03
)
High-Throughput Viscometry with Injectability Screening of High Concentration Protein Formulations by Multiplexed Microfluidic Quartz Resonators
Daniel French
Favorite
Fu, Wenxian
Genentech, Inc.
(
M1030-02-07
)
Pharmacokinetic/Pharmacodynamic Insights into VSIG4 Degrading Antibodies
Wenxian Fu
Favorite
